NCT02495584

Brief Summary

Vitamin D insufficiency has become a global concern, with low vitamin D status associated with bone disorders, cardiovascular disease and certain cancers. The United Kingdom (UK) and Ireland are at particular risk of vitamin D deficiency owing to the northerly latitude, increased use of sunscreen, decreased sun exposure and a high level of cloud cover. A recent survey in the UK showed that more than 50% of UK adults have insufficient vitamin D status, with lower levels noted in the winter months. Variations in vitamin D status have been known to vary between summer and winter, owing to our northern latitude (52-55°N) the Ultraviolet (UV)-B intensity in Northern Ireland is inadequate to promote the dermal synthesis of vitamin D during the winter months, causing us to rely on dietary sources. The aim of this intervention is to investigate the main effects of vitamin D3-fortified milk and supplemental vitamin D3 on vitamin D status and functional health outcomes during the winter, and how this intervention will affect subsequent dermal synthesis of vitamin D from UV exposure. Participants will be recruited from the local community. Blood samples will be collected from each participant at two timepoints (September/October and March/April). Pre- and post-intervention blood pressure, grip strength, height, weight, waist and hip circumferences will be measured, in addition participants will undergo a dual energy x-ray absorptiometry (DXA) scan to assess body composition and bone mineral density. Information on general health, lifestyle, physical activity, dietary intake and typical behaviours in the sun will be collected. Following the dietary intervention, a subset of participants will be invited to participate in a follow-up study, examining UV exposure during the summer months, when they will wear a personal wrist dosimeter for 1 month, complete a sun dairy and provide 2 additional blood samples.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 13, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

January 15, 2016

Status Verified

January 1, 2016

Enrollment Period

1.1 years

First QC Date

May 11, 2015

Last Update Submit

January 14, 2016

Conditions

Keywords

Vitamin DFortified milkSupplementationUV exposureWinterHealthy adultsBody CompositionMuscle functionBlood pressure

Outcome Measures

Primary Outcomes (1)

  • Change in vitamin D status (25-hydroxyvitamin D serum concentration)

    Blood analysis

    Baseline + post-intervention (24weeks)

Secondary Outcomes (6)

  • Change in body composition

    Baseline + post-intervention (24weeks)

  • Change in muscle strength

    Baseline + post-intervention (24weeks)

  • Change in inflammation status

    Baseline + post-intervention (24weeks)

  • Change in lipid profile

    Baseline + post-intervention (24weeks)

  • Change in glucose levels

    Baseline + post-intervention (24weeks)

  • +1 more secondary outcomes

Other Outcomes (1)

  • UV exposure (follow-up)

    8 weeks post-intervention (32-40 weeks)

Study Arms (4)

Treatment 1

EXPERIMENTAL

500ml fortified milk (10µg vitamin D3) +1 supplement capsule (10µg vitamin D3) daily for 24 weeks

Dietary Supplement: Fortified milk (10µg vitamin D3)Dietary Supplement: 10µg vitamin D3 supplement

Treatment 2

EXPERIMENTAL

500ml fortified milk (10µg vitamin D3) +1 supplement capsule (placebo) daily for 24 weeks

Dietary Supplement: Fortified milk (10µg vitamin D3)Dietary Supplement: Placebo supplement

Treatment 3

EXPERIMENTAL

500ml unfortified milk (placebo) +1 supplement capsule (10µg vitamin D3) daily for 24 weeks

Dietary Supplement: Unfortified milk (placebo)Dietary Supplement: 10µg vitamin D3 supplement

Treatment 4

PLACEBO COMPARATOR

500ml unfortified milk (placebo) +1 supplement capsule (placebo) daily for 24 weeks

Dietary Supplement: Unfortified milk (placebo)Dietary Supplement: Placebo supplement

Interventions

Treatment 1Treatment 2
Unfortified milk (placebo)DIETARY_SUPPLEMENT
Treatment 3Treatment 4
10µg vitamin D3 supplementDIETARY_SUPPLEMENT
Treatment 1Treatment 3
Placebo supplementDIETARY_SUPPLEMENT
Treatment 2Treatment 4

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Apparently healthy
  • Living on the island of Ireland

You may not qualify if:

  • Below 20 years and aged 40 years or above
  • Not living on the island of Ireland
  • Pregnant or lactating women and those planning to become pregnant
  • Individuals who have been taking a vitamin D or calcium containing supplement in the previous three months
  • Those with food intolerances or allergies that would affect their ability to consume study milk
  • Individuals following a diet which excludes milk (e.g. vegans)
  • Those with a diagnosed chronic medical condition or on prescribed medication known to effect vitamin D metabolism
  • Those who are planning a sun holiday during the winter months (Oct-Mar)
  • Adults with learning, or any other difficulties that would prevent them from completing the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Intervention Studies Unit

Coleraine, BT52 1SA, United Kingdom

Location

MeSH Terms

Interventions

Cholecalciferol

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2015

First Posted

July 13, 2015

Study Start

September 1, 2014

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

January 15, 2016

Record last verified: 2016-01

Locations